Oncology Treatments Overcoing Immunosuppression

Angarus Therapeutics focuses on developing innovative therapies that leverage advanced technologies to address unmet medical needs in oncology. The company employs a proprietary platform that utilizes a unique approach to target and modulate the immune system, enhancing the body’s ability to fight cancer. This technology is designed to improve the efficacy and safety of cancer treatments, potentially leading to better patient outcomes.

In addition to its immune modulation strategies, Angarus Therapeutics is also engaged in the development of small molecule therapeutics that aim to disrupt cancer cell signaling pathways. By targeting specific molecular mechanisms involved in tumor growth and survival, these small molecules are intended to provide a more precise and effective treatment option for patients. The combination of immune modulation and targeted small molecule therapies positions Angarus Therapeutics at the forefront of cancer treatment innovation.

United States

At Angarus, we are developing a new class of therapeutics that selectively targets immune-activating and immunosuppressive pathways within the tumor microenvironment, using predictive biomarkers for a more powerful, precise, and coordinated attack against cancer.

Angarus Therapeutics

Company Details